Showing results (271-280 of 298) with videos related to

Sort By:
Pageof 30
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 24, 2019
The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: a nationwide analysisTara M Mackay, F Jasmijn Smits, Daphne Roos, et al.
The British Journal of Surgery|November 28, 2025
Oncological outcome after robot-assisted versus open pancreatoduodenectomy for upfront resectable cancer in the pancreatic head: a nationwide cohort analysisJulia E Menso, Caro L Bruna, Mahsoem Ali, et al.
Annals of Surgery|September 17, 2024
Poor Prognostic Factors in Long-Term Survivors of Resected Pancreatic Ductal Adenocarcinoma: An International, Multicenter Cohort StudyAmmar A Javed, Ingmar F Rompen, Iris W J M van Goor, et al.
European Radiology Experimental|December 1, 2023
Deep learning models for automatic tumor segmentation and total tumor volume assessment in patients with colorectal liver metastasesNina J Wesdorp, J Michiel Zeeuw, Sam C J Postma, et al.
British Journal of Cancer|May 28, 2024
The road to tailored adjuvant chemotherapy for all four non-pancreatic periampullary cancers: An international multimethod cohort studyBas A Uijterwijk, Daniël H Lemmers, Michele Ghidini, et al.
Annals of Surgical Oncology|June 18, 2024
The Five Periampullary Cancers, not Just Different Siblings but Different Families: An International Multicenter Cohort StudyBas A Uijterwijk, Daniël H Lemmers, Michele Ghidini, et al.
Pancreas|March 10, 2018
The Dutch Pancreas Biobank Within the Parelsnoer Institute: A Nationwide Biobank of Pancreatic and Periampullary DiseasesMarin Strijker, Arja Gerritsen, Jony van Hilst, et al.
Annals of Surgery|August 12, 2025
Surgical Complications in Patients with (borderline) Resectable Pancreatic Cancer after Neoadjuvant Therapy in the PREOPANC-2 Randomized Controlled TrialEsther N Dekker, Rutger T Theijse, Jacob L van Dam, et al.
European Journal of Cancer (Oxford, England : 1990)|July 14, 2026
Prognostic host phenotypes based on body composition and systemic inflammation predict survival in patients with resected pancreatic and periampullary cancerNicole D Hildebrand, David P J van Dijk, Jisce R Puik, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 21, 2026
Contemporary challenges in long-term survival prediction in resected pancreatic ductal adenocarcinoma: a transatlantic multicenter development and validation of prognostic modelsAmmar A Javed, Mahsoem Ali, Omar Mahmud, et al.
Pageof 30